VTRS Gross Profit History: $5.01B (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	$1.2B−0.3%	$1.5B+9.3%	Not reported	Not reported
FY25	$1.2B−22.8%	$1.3B−7.8%	$1.4B−6.0%	$1.1B−5.5%
FY24	$1.5B−2.5%	$1.4B−10.1%	$1.5B−13.7%	$1.2B−23.9%
FY23	$1.5B−12.9%	$1.6B−5.6%	$1.7B−3.3%	$1.6B+25.3%
FY22	$1.8B+57.1%	$1.7B+28.3%	$1.7B+11.1%	$1.3B−17.6%
Share	24%	26%	28%	23%

01—History

Gross Profit History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

$5.01B

YoY changeLargest recent move+46.9%in FY21Latest −10.8%

02—Ledger

Gross Profit, period by period

Period	Value	Change	Source
FY2025	$5.01B	−10.8%	10-K
FY2024	$5.62B	−12.7%	10-K
FY2023	$6.44B	−0.9%	10-K
FY2022	$6.50B	+16.5%	10-K
FY2021	$5.58B	+46.9%	10-K
FY2020	$3.80B	−2.6%	10-K
FY2019	$3.90B	−2.6%	10-K
FY2018	$4.00B	—	10-K

03—Questions

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is Viatris's current gross profit?

Viatris (VTRS) annual gross profit for 2025 was $5.01B, a 10.85% decline from 2024. Viatris gross profit for the quarter ending June 30, 2026 was $1.46B.

What was Viatris's gross profit in 2024?

Viatris annual gross profit for 2024 was $5.62B, a 12.66% decline from 2023.

What was Viatris's gross profit in 2023?

Viatris annual gross profit for 2023 was $6.44B, a 0.90% decline from 2022.

What is Viatris's 5-year gross profit CAGR?

Viatris gross profit grew at a compound annual growth rate (CAGR) of 5.72% from FY2020 to FY2025, going from $3.80B to $5.01B over 5 years.

Company: Viatris
Ticker: VTRS
Sector: Healthcare
Industry: Pharmaceutical Preparations

Viatris Gross Profit 2018-2026 | VTRS

Key Statistics